Not "worst advice ever". I wouldn't call the following dreaming:
- strong preclinical data,
- world first Human trial soon to start using Allogeneic IPSC-derived MSC's
- Fujifilm acquires 9% of CYP and has all the resources to do due diligence
CYP needs to expand visibility whilst they move towards revenues and other milestones
DYOR
Fuji knows better, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $37.94M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 21.0¢ | $423 | 2.016K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41003 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10656 | 1 |
View Market Depth
| Last trade - 12.11pm 27/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |